Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Dexcom (DXCM) over the last 8 years, with Q4 2025 value amounting to $2.1 billion.

  • Dexcom's Treasury Shares rose 3184.92% to $2.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.1 billion, marking a year-over-year increase of 3184.92%. This contributed to the annual value of $2.1 billion for FY2025, which is 3184.92% up from last year.
  • Dexcom's Treasury Shares amounted to $25.9 million in Q4 2025, which was up 14903.85% from $20.6 million recorded in Q3 2025.
  • In the past 5 years, Dexcom's Treasury Shares ranged from a high of $25.9 million in Q4 2025 and a low of $100000.0 during Q1 2022
  • In the last 5 years, Dexcom's Treasury Shares had a median value of $7.4 million in 2022 and averaged $8.9 million.
  • Per our database at Business Quant, Dexcom's Treasury Shares plummeted by 6270.0% in 2022 and then surged by 200214.48% in 2023.
  • Over the past 5 years, Dexcom's Treasury Shares (Quarter) stood at $206.2 million in 2021, then skyrocketed by 188.55% to $595.0 million in 2022, then skyrocketed by 311.95% to $2.5 billion in 2023, then crashed by 35.49% to $1.6 billion in 2024, then skyrocketed by 31.85% to $2.1 billion in 2025.
  • Its Treasury Shares stands at $2.1 billion for Q4 2025, versus $1.8 billion for Q3 2025 and $1.6 billion for Q2 2025.